Patients exhibiting concurrent high infiltration of CD4+ Th1 and CD8+ T cells and elevated ICAM, ITGAL, and ITGB2 expression had the best clinical outcomes out of the patients with melanoma (Figure 7B). This evidence concerns the gene ITGAL and melanoma.